I have been fortunate to have spent my career on early-stage medical device start-ups. These start-ups have resulted in exits in excess of $500M in shareholder value. As founder and CEO of Kerberos Proximal Solutions (sold to Fox Hollow Technologies), as COO for Maya Medical (sold to Covidien) and as the General Manager for Claret (sold to Boston Scientific) we have built teams that balance excellent engineering with front-line clinical feedback for the benefit of patient's lives.